MISSED BY OTHERS, DETECTED BY US
Genomic Unity® Case Study
Clinical presentation
A 12-year-old female presented with suspicion of Lennox-Gastaut syndrome. Her complex medical history and symptoms included:
- Seizures
- Global developmental delay and regression
- Autism
- Recurrent aspiration pneumonia
- Encephalopathy
- Gait disturbance
- Generalized amyotrophy
- Astigmatism, strabismus, myopia
Previous genetic testing
Testing was performed with negative results including:
- Epilepsy panel
- Whole exome sequencing
Genomic Unity® Testing
was ordered because of its ability to identify all major variant types in a single test.
Results and interpretation
Variantyx Genomic Unity® testing identified a heterozygous, likely pathogenic single nucleotide deletion in the SEMA6B gene. The p.Val675PhefsTer10 change results in a frameshift and early termination of the protein in exon 17 (the final exon). The change is not expected to result in nonsense-mediated mRNA decay and benign haploinsufficiency, but to result in a truncated protein that exerts a negative, interfering effect on signaling.
Pathogenic SEMA6B variants associated with autosomal dominant myoclonic epilepsy and intellectual disability are clustered here in exon 17 1.
Diagnosis: Progressive myoclonic epilepsy 11
Uniform data from WGS clearly shows the single nucleotide deletion.
The Variantyx Difference
Why was this indel detected by Genomic Unity® testing, and not detected by other tests?
-
The epilepsy panel did not include the SEMA6B gene.
Variantyx genome analysis covers all genes with a detection range from 1 bp to whole chromosomal events, easily detecting this indel. -
Exome tests should have detected this variant. The region looks to be well covered by commercial exome probe kits and is not notable for repetitive sequences likely to interfere with amplification. Despite this, the limitations for the test chosen specified only 93% coverage of the SEMA6B gene.
Variantyx genome analysis covers the entire SEMA6B gene, easily detecting this indel. -
Accurate variant interpretation requires recognizing that this distal truncating variant is associated with different and/or more severe phenotypes than truncating variants located earlier in the gene. Less fine-tuned bioinformatics pipelines may not recognize and flag this.
Variantyx variant scientists have interpretation capabilities that enable thorough investigation of every variant, oftentimes uncovering atypical presentations.
Variantyx tests that would have identified this variant
Genomic Unity® 2.0 | Genomic Unity® Whole Genome Analysis | Genomic Unity® Lightning Genome Analysis | Genomic Unity® Lightning 2.0 Genome Analysis – NICU | Genomic Unity® Lightning 2.0 Genome Analysis – Standard | Genomic Unity® Exome Plus Analysis | Genomic Unity® Exome Analysis | Genomic Unity® Epilepsy Analysis
References
Want similar results for your patients?
Connect with a Clinical Specialist to find out how easy it is to bring the power of whole genome sequencing into your practice.